Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Liver Cirrhosis, Biliary

cetylpyridinium chloride anhydrous has been researched along with Liver Cirrhosis, Biliary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alyea, EP; Bellucci, R; Gallagher, M; Gershwin, ME; Li, S; Munshi, NC; Oertelt, S; Porcheray, F; Ritz, J; Soiffer, RJ; Weller, E; Zorn, E1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Liver Cirrhosis, Biliary

ArticleYear
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
    Blood, 2007, Mar-01, Volume: 109, Issue:5

    Topics: Aged; Antibodies; Cell Line, Tumor; Dihydrolipoyllysine-Residue Acetyltransferase; Epitope Mapping; Female; Health; Hematopoietic Stem Cell Transplantation; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondrial Proteins; Paraproteinemias; Transplantation, Homologous

2007